Behavioural Genetics of Alzheimer's Disease: a Comprehensive Review

Overview

Journal Arch Med Sci

Specialty General Medicine

Date 2012 Feb 1

PMID 22291757

Citations 13

Authors

Marcin Flirski

Tomasz Sobow

Iwona Kloszewska

Affiliations

Soon will be listed here.

Abstract

Behavioural and psychological symptoms of dementia (BPSD) are present in the course of the illness in up to 90% of patients with Alzheimer's disease (AD). They are the main source of caregiver burden and one of the major factors contributing to early institutionalization. The involvement of a genetic component in BPSD aetiology seems beyond controversy, though the exact significance of particular polymorphisms is uncertain in the majority of cases. Multiple genes have been assessed for their putative influence on BPSD risk. In this paper we review the behavioural genetics of AD, particularly the importance, with respect to BPSD risk, of genes coding for apolipoprotein E and proteins involved in the process of neurotransmission: serotonin receptors, serotonin transporter, COMT, MAO-A, tryptophan hydroxylase and dopamine receptors. A general conclusion is the striking inconsistency of the findings, unsurprising in the field of psychiatric genetics. The potential reasons for such discrepancy are exhaustively discussed.

Citing Articles

BPSDiary study protocol: a multi-center randomized controlled trial to compare the efficacy of a BPSD diary vs. standard care in reducing caregiver's burden.

Pozzi F, Cali L, DAntonio F, Altomare A, Sepe Monti M, Panigutti M Front Dement. 2024; 2:1301280.

PMID: 39081982 PMC: 11285609. DOI: 10.3389/frdem.2023.1301280.

Searching for new drugs for the treatment of dementia-related psychosis.

Zakrzewska-Sito A, Kuczynska J Postep Psychiatr Neurol. 2023; 30(4):270-277.

PMID: 37082556 PMC: 9881640. DOI: 10.5114/ppn.2021.111942.

Serotonin 2 Receptors, Agomelatine, and Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease.

Li H, Yao X, Tao S, Sun X, Li P, Li X Behav Neurol. 2021; 2021:5533827.

PMID: 33859767 PMC: 8026319. DOI: 10.1155/2021/5533827.

Behavioral and Psychological Symptoms of Dementia (BPSD): Clinical Characterization and Genetic Correlates in an Italian Alzheimer's Disease Cohort.

Scassellati C, Ciani M, Maj C, Geroldi C, Zanetti O, Gennarelli M J Pers Med. 2020; 10(3).

PMID: 32823921 PMC: 7563608. DOI: 10.3390/jpm10030090.

Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach.

Scuteri D, Rombola L, Morrone L, Bagetta G, Sakurada S, Sakurada T Int J Mol Sci. 2019; 20(13).

PMID: 31284573 PMC: 6651821. DOI: 10.3390/ijms20133327.

References

DSouza U, Craig I . Functional genetic polymorphisms in serotonin and dopamine gene systems and their significance in behavioural disorders. Prog Brain Res. 2008; 172:73-98. DOI: 10.1016/S0079-6123(08)00904-7. View

Lanctot K, Herrmann N, Nadkarni N, Leibovitch F, Caldwell C, Black S . Medial temporal hypoperfusion and aggression in Alzheimer disease. Arch Neurol. 2004; 61(11):1731-7. DOI: 10.1001/archneur.61.11.1731. View

Sweet R, Pollock B, Sukonick D, Mulsant B, Rosen J, Klunk W . The 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer disease. Int Psychogeriatr. 2002; 13(4):401-9. DOI: 10.1017/s1041610201007827. View

Luddington N, Mandadapu A, Husk M, El-Mallakh R . Clinical implications of genetic variation in the serotonin transporter promoter region: a review. Prim Care Companion J Clin Psychiatry. 2009; 11(3):93-102. PMC: 2708005. DOI: 10.4088/pcc.08r00656. View

Sweet R, Kamboh M, Wisniewski S, Lopez O, Klunk W, Kaufer D . Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease. J Geriatr Psychiatry Neurol. 2002; 15(1):24-30. DOI: 10.1177/089198870201500106. View

Hirono N, Mori E, Yasuda M, Imamura T, Shimomura T, Hashimoto M . Lack of effect of apolipoprotein E E4 allele on neuropsychiatric manifestations in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1999; 11(1):66-70. DOI: 10.1176/jnp.11.1.66. View

Kim J, Basak J, Holtzman D . The role of apolipoprotein E in Alzheimer's disease. Neuron. 2009; 63(3):287-303. PMC: 3044446. DOI: 10.1016/j.neuron.2009.06.026. View

Pritchard A, Ratcliffe L, Sorour E, Haque S, Holder R, Bentham P . Investigation of dopamine receptors in susceptibility to behavioural and psychological symptoms in Alzheimer's disease. Int J Geriatr Psychiatry. 2009; 24(9):1020-5. DOI: 10.1002/gps.2214. View

Micheli D, Bonvicini C, Rocchi A, Ceravolo R, Mancuso M, Tognoni G . No evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease. J Alzheimers Dis. 2006; 10(4):371-8. DOI: 10.3233/jad-2006-10405. View

10.

Robertson J, Curley J, Kaye J, Quinn J, Pfankuch T, Raber J . apoE isoforms and measures of anxiety in probable AD patients and Apoe-/- mice. Neurobiol Aging. 2005; 26(5):637-43. DOI: 10.1016/j.neurobiolaging.2004.06.003. View

11.

Ueki A, Ueno H, Sato N, Shinjo H, Morita Y . Serotonin transporter gene polymorphism and BPSD in mild Alzheimer's disease. J Alzheimers Dis. 2007; 12(3):245-53. DOI: 10.3233/jad-2007-12306. View

12.

Hu X, Lipsky R, Zhu G, Akhtar L, Taubman J, Greenberg B . Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet. 2006; 78(5):815-826. PMC: 1474042. DOI: 10.1086/503850. View

13.

Holmes C, Smith H, Ganderton R, Arranz M, Collier D, Powell J . Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation. J Neurol Neurosurg Psychiatry. 2001; 71(6):777-9. PMC: 1737623. DOI: 10.1136/jnnp.71.6.777. View

14.

Pritchard A, Harris J, Pritchard C, Coates J, Haque S, Holder R . The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2006; 78(2):123-6. PMC: 2077651. DOI: 10.1136/jnnp.2006.092122. View

15.

Sato N, Ueki A, Ueno H, Shinjo H, Morita Y . IDE Gene Polymorphism Influences on BPSD in Mild Dementia of Alzheimer's Type. Curr Gerontol Geriatr Res. 2009; :858759. PMC: 2671997. DOI: 10.1155/2008/858759. View

16.

Spalletta G, Bernardini S, Bellincampi L, Federici G, Trequattrini A, Ciappi F . Glutathione S-transferase P1 and T1 gene polymorphisms predict longitudinal course and age at onset of Alzheimer disease. Am J Geriatr Psychiatry. 2007; 15(10):879-87. DOI: 10.1097/JGP.0b013e3180547076. View

17.

Holmes C, Levy R, McLoughlin D, Powell J, Lovestone S . Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1996; 61(6):580-3. PMC: 486650. DOI: 10.1136/jnnp.61.6.580. View

18.

Pritchard A, Pritchard C, Bentham P, Lendon C . Investigation of the role of the dopamine transporter in susceptibility to behavioural and psychological symptoms of patients with probable Alzheimer's disease. Dement Geriatr Cogn Disord. 2008; 26(3):257-60. DOI: 10.1159/000160958. View

19.

Grunblatt E, Zehetmayer S, Bartl J, Loffler C, Wichart I, Rainer M . Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study. J Psychiatr Res. 2008; 43(3):298-308. DOI: 10.1016/j.jpsychires.2008.05.008. View

20.

Akil M, Kolachana B, Rothmond D, Hyde T, Weinberger D, Kleinman J . Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci. 2003; 23(6):2008-13. PMC: 6742018. View